Proximal Ventures Launches $27.5M Debut Fund to Back AI in Drug Development
Proximal Ventures, a new venture firm, has closed a debut fund of $27.5 million. The fund was raised by Sahir Raoof, a former investor at SignalFire. Its stated focus is backing startups that apply artificial intelligence to drug development. The announcement signals continued investor interest in using AI within the pharmaceutical sector.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.



Discussion (0)
Log in to join the discussion and vote.
Log in